Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 1G.1G.1G). We employs the AAV (SV40-Cy5-IL-4-HindIII) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
human
Target
CCL2
Clone
1G.1G.1G
Species Reactivity
human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy5
Promoter
SV40
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
AAV
Transformation Accuracy
0.86
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.